Cargando…
Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study
Background Congenital heart conditions often cause developmental delays and impact neurodevelopment throughout one’s lifetime. Hence, it is crucial to analyze the impact that heart defects have on the developing brain of a child. The present cross-sectional study was undertaken given the paucity of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897704/ https://www.ncbi.nlm.nih.gov/pubmed/36751205 http://dx.doi.org/10.7759/cureus.33373 |
_version_ | 1784882309405605888 |
---|---|
author | Vagha, Keta Taksande, Amar Kenjale, Sneha Vagha, Jayant Varma, Ashish |
author_facet | Vagha, Keta Taksande, Amar Kenjale, Sneha Vagha, Jayant Varma, Ashish |
author_sort | Vagha, Keta |
collection | PubMed |
description | Background Congenital heart conditions often cause developmental delays and impact neurodevelopment throughout one’s lifetime. Hence, it is crucial to analyze the impact that heart defects have on the developing brain of a child. The present cross-sectional study was undertaken given the paucity of studies on the developmental status in children with congenital heart diseases (CHDs) in central India, where we tried to evaluate and compare the prevalence of neurodevelopmental delay in individuals with different congenital cardiac disorders. The objectives of our study were, firstly, to utilize the Denver Developmental Screening Test 2 (DDST-2) to evaluate the neurodevelopmental conditions in children with CHD; secondly, to compare the neurodevelopmental state of children with acyanotic CHD (ACHD) and cyanotic CHD (CCHD); and thirdly, to ascertain the prevalence of developmental delay in children with CHD. Methodology The study population comprised children aged six months to six years with two-dimensional (2D) echocardiography confirmation of CHD; those who were critically ill, had genetic syndromes, and were not willing to participate in the study were excluded. The neurodevelopmental assessment was conducted using the DDST-2. The screening looked at each patient’s progress in four areas: personal-social, fine motor-adaptive, language, and gross motor. Based on these observations, results were obtained and interpreted. Result Out of 82 children with CHD, the prevalence rate of developmental delay according to the DDST-2 was found to be maximum in the gross motor domain and the least affected in the social domain, which was similar to the analysis of developmental delay by developmental quotient (DQ). The comparative analysis of developmental delay in ACHD and CCHD according to the DDST-2 showed a significant P value only in the gross motor domain. Conclusion The DDST-2 is a straightforward screening tool for determining how well-developed infants with CHD are. The gross motor domain is the most frequently damaged in ACHD and CCHD, followed by the fine motor domain, and the social domain is the least affected. Cyanotic CHD patients are more susceptible to developmental delay than children with ACHD. |
format | Online Article Text |
id | pubmed-9897704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-98977042023-02-06 Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study Vagha, Keta Taksande, Amar Kenjale, Sneha Vagha, Jayant Varma, Ashish Cureus Cardiology Background Congenital heart conditions often cause developmental delays and impact neurodevelopment throughout one’s lifetime. Hence, it is crucial to analyze the impact that heart defects have on the developing brain of a child. The present cross-sectional study was undertaken given the paucity of studies on the developmental status in children with congenital heart diseases (CHDs) in central India, where we tried to evaluate and compare the prevalence of neurodevelopmental delay in individuals with different congenital cardiac disorders. The objectives of our study were, firstly, to utilize the Denver Developmental Screening Test 2 (DDST-2) to evaluate the neurodevelopmental conditions in children with CHD; secondly, to compare the neurodevelopmental state of children with acyanotic CHD (ACHD) and cyanotic CHD (CCHD); and thirdly, to ascertain the prevalence of developmental delay in children with CHD. Methodology The study population comprised children aged six months to six years with two-dimensional (2D) echocardiography confirmation of CHD; those who were critically ill, had genetic syndromes, and were not willing to participate in the study were excluded. The neurodevelopmental assessment was conducted using the DDST-2. The screening looked at each patient’s progress in four areas: personal-social, fine motor-adaptive, language, and gross motor. Based on these observations, results were obtained and interpreted. Result Out of 82 children with CHD, the prevalence rate of developmental delay according to the DDST-2 was found to be maximum in the gross motor domain and the least affected in the social domain, which was similar to the analysis of developmental delay by developmental quotient (DQ). The comparative analysis of developmental delay in ACHD and CCHD according to the DDST-2 showed a significant P value only in the gross motor domain. Conclusion The DDST-2 is a straightforward screening tool for determining how well-developed infants with CHD are. The gross motor domain is the most frequently damaged in ACHD and CCHD, followed by the fine motor domain, and the social domain is the least affected. Cyanotic CHD patients are more susceptible to developmental delay than children with ACHD. Cureus 2023-01-04 /pmc/articles/PMC9897704/ /pubmed/36751205 http://dx.doi.org/10.7759/cureus.33373 Text en Copyright © 2023, Vagha et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Vagha, Keta Taksande, Amar Kenjale, Sneha Vagha, Jayant Varma, Ashish Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study |
title | Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study |
title_full | Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study |
title_fullStr | Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study |
title_full_unstemmed | Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study |
title_short | Neurodevelopmental Assessment in Children With Congenital Heart Disease by Applying the Denver Developmental Screening Test 2: A Prospective Cross-Sectional Study |
title_sort | neurodevelopmental assessment in children with congenital heart disease by applying the denver developmental screening test 2: a prospective cross-sectional study |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897704/ https://www.ncbi.nlm.nih.gov/pubmed/36751205 http://dx.doi.org/10.7759/cureus.33373 |
work_keys_str_mv | AT vaghaketa neurodevelopmentalassessmentinchildrenwithcongenitalheartdiseasebyapplyingthedenverdevelopmentalscreeningtest2aprospectivecrosssectionalstudy AT taksandeamar neurodevelopmentalassessmentinchildrenwithcongenitalheartdiseasebyapplyingthedenverdevelopmentalscreeningtest2aprospectivecrosssectionalstudy AT kenjalesneha neurodevelopmentalassessmentinchildrenwithcongenitalheartdiseasebyapplyingthedenverdevelopmentalscreeningtest2aprospectivecrosssectionalstudy AT vaghajayant neurodevelopmentalassessmentinchildrenwithcongenitalheartdiseasebyapplyingthedenverdevelopmentalscreeningtest2aprospectivecrosssectionalstudy AT varmaashish neurodevelopmentalassessmentinchildrenwithcongenitalheartdiseasebyapplyingthedenverdevelopmentalscreeningtest2aprospectivecrosssectionalstudy |